Cyclobenzaprine Hydrochloride Capsule, Extended Release
Product Images NDC 80425-0451

Product Visual Gallery

This gallery contains 10 technical images submitted to the FDA as part of the official labeling for Cyclobenzaprine Hydrochloride (NDC 80425-0451). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Advanced Rx Of Tennessee, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Cyclobenzaprine HCl Er 15mg #30 (Cyclobenzaprine HCl Er 15mg 80425 0451 01)

Label for Cyclobenzaprine Hydrochloride Extended Release 15 mg capsule, package of 30 units. The label includes NDC 80425-0451-01, lot number placeholder, and expiration date 3/31/2027. It is labeled for Advanced Rx of Tennessee, LLC, and also references TEVA USA with a serial number. The label advises storage at 20°-25°C and cautions against transfer of this drug to others.*

FDA Label Image

Cyclobenzaprine HCl Er 15mg #60 (Cyclobenzaprine HCl Er 15mg 80425 0451 02)

Label for Cyclobenzaprine Hydrochloride Extended Release 15 mg capsule, packaged by Advanced Rx in Nashville, TN. The label includes storage instructions at 20°-25°C, a barcode, comparison to an Amrix product NDC, lot number placeholder, and expiration date 3/31/2027. The label states Rx Only and references TEVA USA with a serial number.*

FDA Label Image

Cyclobenzaprine HCl Er 15mg #90 (Cyclobenzaprine HCl Er 15mg 80425 0451 03)

Cyclobenzaprine Hydrochloride Extended Release 15 mg capsule label by Advanced Rx of Tennessee, LLC. The label includes the proprietary name, dosage strength, NDC 80425-0451-03, barcode, and storage instructions at 20°-25°C (68°-77°F). It notes prescription-only status and batch expiry date as 3/31/2027.*

FDA Label Image

Structural Formula (Image 1)

Chemical structure of Cyclobenzaprine Hydrochloride depicting a tricyclic compound with a hydrochloride salt, consistent with the generic drug Cyclobenzaprine Hydrochloride.*

FDA Label Image

Image (Image 2)

An illustration in black and white of a spoon holding a scoop of an unspecified substance, possibly powder or cream, with simple line shading and no text.*

FDA Label Image

Image (Image 3)

An instructional illustration showing two hands holding a capsule labeled "TOP," demonstrating the correct orientation or handling technique.*

FDA Label Image

Image (Image 4)

An instructional illustration showing hands twisting a child-resistant safety cap labeled "TOP." The arrows indicate the direction to turn the cap for opening or closing, demonstrating how to operate the safety closure mechanism on a medication container.*

FDA Label Image

Image (Image 5)

An instructional illustration depicting a hand opening a capsule, with small round beads or pellets spilling onto a spoon or surface below.*

FDA Label Image

Image (Image 6)

An illustration shows a woman holding a spoon with medication near her mouth, demonstrating the oral administration of a drug.*

FDA Label Image

Image (Image 7)

An illustration of a person drinking from a glass. The image depicts the action of oral ingestion, likely related to taking a medication or liquid by mouth.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.